Navigation Links
Co-Founder of Omega3 Innovations Says Today’s Fish Oil Industry is on the Wrong Track, Sets Up Blog to Help Consumers Understand Why
Date:1/15/2013

Venice, FL (PRWEB) January 15, 2013

For 16 years, Dr. Bo Martinsen – co-founder of Venice-based Omega3 Innovations – has championed omega-3 fish oils by touting the fatty acids’ numerous health benefits at both national and international speaking engagements.

“As a physician, I always tell my patients, if there is one simple thing you can do for your health, take a solid dose of omega-3 fish oil every day,” Martinsen says.

But recently, Martinsen, who co-owns the biotech company with Dr. Anne-Marie Chalmers, witnessed a growing trend in the industry – the market shift toward highly-concentrated fish oil supplements – that convinced him to alter his advice. As the market for fish oil grows, concentrates are becoming increasingly popular both in prescription and over-the-counter form.

A quick look around your local pharmacy shows the increasing presence of concentrated omega-3s, says Martinsen, who cites market growth projections of eight percent a year through 2020 (1).

And, the growth spurt in products created by this type of manufacturing process has him worried.

“I used to think that as long as we took an adequate dose of omega-3 every day, the type of oil didn’t matter,” he says. “But, the more I work with omega-3, the more I see that the quality and manufacturing process of the oil is crucial to consumer health.”

Martinsen says that some manufacturers – in an effort to increase the essential fatty acids EPA and DHA in the fish oil – transform the acids into new chemical structures known as ethyl esters. He notes that ethyl esters exist neither in nature, nor in the human body.

His research on chemically modified omega-3s versus natural fish oils has led him to create a blog titled “Seven Reasons the Omega-3 Industry is on the Wrong Track.”

“When we start changing the chemical structure of the omega-3 molecules, the body responds differently to the modified oil than it does to natural fish oil,” he explains. “Just like with genetically modified organisms, these chemical modifications are troubling because we don’t know how the body will fully respond for years.”

Martinsen says some other negative issues with concentrated omega-3s are rancidity, fewer fatty acids and natural vitamins, environmental waste, and the fact that they can be more expensive.

“The fact is that people can get the same amount of EPA and DHA from natural sources as is advertised in the concentrated products,” he says. “I believe we would all benefit greatly if the industry focused instead on improving the technology for making liquid fish oil that is fresh and sustainable.”

Reference
1. Matthews, Sheenagh. “BASF to Pay $654 Million for Pronova to be Leader in Omega-3.” Bloomberg.com. Nov. 21, 2012.

For more information about this release, please contact:
Anne-Marie Chalmers, M.D., Omega3 Innovations, 941-485-4400 or am(at)omega3innovations(dot)com
Bo Martinsen, M.D., Omega3 Innovations, 941-485-4400 or bo(at)omega3innovations(dot)com
Charlene Hager-Van Dyke, Larry Vershel Communications, 407-644-4142, 386-532-8862, or chagervandyke(at)yahoo(dot)com

Read the full story at http://www.prweb.com/releases/2013/1/prweb10301066.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Omega3 Innovations Helps Local Food Bank Provide Thanksgiving Dinners for those in Need
2. Invisalign® Available at Smile Innovations
3. Smile Innovations Announces New Care Credit Payment Option for Clients
4. MSU invention could help pharmaceutical industry save money
5. More cutting-edge cancer research supported by industry
6. Ultra-short laser pulses for science and industry
7. Beef & Pork Wholesaling in the US Industry Market Research Report Now Available from IBISWorld
8. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
9. Advertising Industry Veteran Pat McCrossan Joins Mangos
10. Trivedi Beef, LLC Announces Breakthrough Beef Industry Data without the use of Antibiotic Drugs, Hormones or Steroids
11. QTrade's New Facility Anticipates Dramatic Growth of Tea Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... California (PRWEB) , ... June 27, 2016 , ... "FCPX ... fully customizable inside of Final Cut Pro X," said Christina Austin - CEO of ... unique style. Final Cut Pro X users can now reveal the media ...
(Date:6/26/2016)... ... 2016 , ... Quality metrics are proliferating in cancer care, and are derived ... eye of the beholder, according to experts who offered insights and commentary in the ... Care. For the full issue, click here . , For the American Society ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/24/2016)... Los Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... plastic surgery procedures that most people are unfamiliar with. The article goes on to ... known procedures, but also many of these less common operations such as calf and ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Any dentist who ... challenges of the current process. Many of them do not ... the technical difficulties and high laboratory costs involved. And those ... offer it at such a high cost that the majority ... Dr. Parsa Zadeh , founder of Dental ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
(Date:6/23/2016)... -- Research and Markets has announced the addition ... to their offering. The ... commercial environment for MedImmune to enter. The US ageing population ... to drive considerable growth for effective anti-influenza medications. The introduction ... considerably, but development is still in its infancy. ...
Breaking Medicine Technology: